Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016190330> ?p ?o ?g. }
- W2016190330 endingPage "2606" @default.
- W2016190330 startingPage "2599" @default.
- W2016190330 abstract "This study presents previously unpublished point and cumulative incidence rates and relative risks (RRs) for comparing a partially hydrolysed 100% whey-based infant formula, NAN-HA * (PHF-W) to extensively hydrolysed whey- (EHF-Whey) or casein-based (EHF-Casein) infant formulas in the prevention of atopic dermatitis (AD) in infants who cannot be breastfed exclusively. It also outlines methods to convert the above-mentioned data as well as data comparing PHF-W to cows' milk formula (SF) into inputs to be applied to a pharmacoeconomic model. * NAN-HA is a registered trade name of Nestlé SA, Switzerland.The incidence rates and RRs were obtained from a meta-analysis which analysed efficacy for PHF-W vs. EHF but did not present those. It took into consideration any relevant randomized controlled trial which compared the use of PHF-W with SF or EHF for the prevention of allergies. The primary outcomes of interest were the incidence, cumulative incidence and period prevalence of allergic manifestations and of AD in particular. Fifteen studies had been included for analysis of which six studies explored PHF-W vs. EHF. These results and PHF-W vs. SF data were adapted for inputs into a pharmacoeconomic model which used a spreadsheet decision-analytic economic model based on 3-month cycles to explore the cost-effectiveness of PHF-W vs. SF and EHF. Weights were applied to the incidence rates and RRs for each reported time period which were then adapted into 3-month indicators.This meta-analysis for PHF-W (557 patients) vs. EHF-Whey (559 patients) yielded RR of 0.75 (0.54, 1.05) and 0.80 (0.63, 1.02) at 0-12 months and at 0-36 months, respectively. Corresponding RRs for PHF-W vs. EHF-Casein (580 patients) were 1.06 (0.74, 1.53) at 0-12 months and 1.13 (0.87, 1.47) at 0-36 months.It appears that the efficacy of PHF-W falls within the range of that of both EHF formulas (whey and casein) and allows the application of these results in a pharmacoeconomic model." @default.
- W2016190330 created "2016-06-24" @default.
- W2016190330 creator A5008581830 @default.
- W2016190330 creator A5023296155 @default.
- W2016190330 creator A5031570144 @default.
- W2016190330 creator A5032676857 @default.
- W2016190330 creator A5034132029 @default.
- W2016190330 date "2010-10-06" @default.
- W2016190330 modified "2023-09-26" @default.
- W2016190330 title "Meta-analysis of a partially hydrolysed 100%-whey infant formula vs. extensively hydrolysed infant formulas in the prevention of atopic dermatitis" @default.
- W2016190330 cites W1972217484 @default.
- W2016190330 cites W1972571084 @default.
- W2016190330 cites W1974141648 @default.
- W2016190330 cites W1988434806 @default.
- W2016190330 cites W2000460621 @default.
- W2016190330 cites W2019237965 @default.
- W2016190330 cites W2084893128 @default.
- W2016190330 cites W2094608990 @default.
- W2016190330 cites W2128144341 @default.
- W2016190330 cites W2143453408 @default.
- W2016190330 cites W2143982789 @default.
- W2016190330 cites W2158746485 @default.
- W2016190330 doi "https://doi.org/10.1185/03007995.2010.525475" @default.
- W2016190330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20925453" @default.
- W2016190330 hasPublicationYear "2010" @default.
- W2016190330 type Work @default.
- W2016190330 sameAs 2016190330 @default.
- W2016190330 citedByCount "25" @default.
- W2016190330 countsByYear W20161903302012 @default.
- W2016190330 countsByYear W20161903302013 @default.
- W2016190330 countsByYear W20161903302014 @default.
- W2016190330 countsByYear W20161903302015 @default.
- W2016190330 countsByYear W20161903302016 @default.
- W2016190330 countsByYear W20161903302017 @default.
- W2016190330 countsByYear W20161903302018 @default.
- W2016190330 countsByYear W20161903302019 @default.
- W2016190330 countsByYear W20161903302021 @default.
- W2016190330 crossrefType "journal-article" @default.
- W2016190330 hasAuthorship W2016190330A5008581830 @default.
- W2016190330 hasAuthorship W2016190330A5023296155 @default.
- W2016190330 hasAuthorship W2016190330A5031570144 @default.
- W2016190330 hasAuthorship W2016190330A5032676857 @default.
- W2016190330 hasAuthorship W2016190330A5034132029 @default.
- W2016190330 hasConcept C126322002 @default.
- W2016190330 hasConcept C16005928 @default.
- W2016190330 hasConcept C168563851 @default.
- W2016190330 hasConcept C185592680 @default.
- W2016190330 hasConcept C187212893 @default.
- W2016190330 hasConcept C203014093 @default.
- W2016190330 hasConcept C207480886 @default.
- W2016190330 hasConcept C2524010 @default.
- W2016190330 hasConcept C2776027960 @default.
- W2016190330 hasConcept C2776142715 @default.
- W2016190330 hasConcept C2778329239 @default.
- W2016190330 hasConcept C2779150110 @default.
- W2016190330 hasConcept C2781372412 @default.
- W2016190330 hasConcept C2911091166 @default.
- W2016190330 hasConcept C31903555 @default.
- W2016190330 hasConcept C33923547 @default.
- W2016190330 hasConcept C44249647 @default.
- W2016190330 hasConcept C61511704 @default.
- W2016190330 hasConcept C71924100 @default.
- W2016190330 hasConcept C82789193 @default.
- W2016190330 hasConcept C88879693 @default.
- W2016190330 hasConcept C95190672 @default.
- W2016190330 hasConceptScore W2016190330C126322002 @default.
- W2016190330 hasConceptScore W2016190330C16005928 @default.
- W2016190330 hasConceptScore W2016190330C168563851 @default.
- W2016190330 hasConceptScore W2016190330C185592680 @default.
- W2016190330 hasConceptScore W2016190330C187212893 @default.
- W2016190330 hasConceptScore W2016190330C203014093 @default.
- W2016190330 hasConceptScore W2016190330C207480886 @default.
- W2016190330 hasConceptScore W2016190330C2524010 @default.
- W2016190330 hasConceptScore W2016190330C2776027960 @default.
- W2016190330 hasConceptScore W2016190330C2776142715 @default.
- W2016190330 hasConceptScore W2016190330C2778329239 @default.
- W2016190330 hasConceptScore W2016190330C2779150110 @default.
- W2016190330 hasConceptScore W2016190330C2781372412 @default.
- W2016190330 hasConceptScore W2016190330C2911091166 @default.
- W2016190330 hasConceptScore W2016190330C31903555 @default.
- W2016190330 hasConceptScore W2016190330C33923547 @default.
- W2016190330 hasConceptScore W2016190330C44249647 @default.
- W2016190330 hasConceptScore W2016190330C61511704 @default.
- W2016190330 hasConceptScore W2016190330C71924100 @default.
- W2016190330 hasConceptScore W2016190330C82789193 @default.
- W2016190330 hasConceptScore W2016190330C88879693 @default.
- W2016190330 hasConceptScore W2016190330C95190672 @default.
- W2016190330 hasIssue "11" @default.
- W2016190330 hasLocation W20161903301 @default.
- W2016190330 hasLocation W20161903302 @default.
- W2016190330 hasOpenAccess W2016190330 @default.
- W2016190330 hasPrimaryLocation W20161903301 @default.
- W2016190330 hasRelatedWork W203516668 @default.
- W2016190330 hasRelatedWork W2051112141 @default.
- W2016190330 hasRelatedWork W2075036833 @default.
- W2016190330 hasRelatedWork W2114346778 @default.
- W2016190330 hasRelatedWork W2259580271 @default.
- W2016190330 hasRelatedWork W2335438131 @default.